Inhibrx, Inc. Common Stock
INBX
INBX was delisted on the 29th of May, 2024.
66 hedge funds and large institutions have $682M invested in Inhibrx, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 4 closing their positions.
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
39% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 18
27% more capital invested
Capital invested by funds: $538M → $682M (+$143M)
8% more funds holding
Funds holding: 61 → 66 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$9.65M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.13M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
+$8.57M |
| 4 |
PA
Perceptive Advisors
New York
|
+$6.52M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$15.7M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$11M |
| 3 |
Millennium Management
New York
|
-$8.15M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$4.41M |
| 5 |
TCM
Tybourne Capital Management
Hong Kong
|
-$2.18M |
INBX Hedge Fund Activity: Q3 2021 in Review
66 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q3 2021, worth a combined $682M — up 27% from $538M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new INBX positions and 4 closed out — a net gain of 5 holders — while 25 added to existing stakes and 18 trimmed.
The largest buyer was Darwin Global Management, adding an estimated $9.65M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $15.7M sold.
- 66 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q3 2021, up from 61 in Q2 2021.
- Funds reported $682M of Inhibrx, Inc. Common Stock stock for Q3 2021, up 27% quarter-over-quarter.
- 9 funds opened new Inhibrx, Inc. Common Stock positions in Q3 2021 and 4 closed out, a net change of +5 holders.
- The largest Inhibrx, Inc. Common Stock buyer in Q3 2021 was Darwin Global Management, an estimated $9.65M added.
- The largest Inhibrx, Inc. Common Stock seller in Q3 2021 was Farallon Capital Management, an estimated $15.7M sold.
Based on aggregated 13F filings for Q3 2021.